Day: May 14, 2025

FORT MILL, S.C., May 14, 2025 (GLOBE NEWSWIRE) — Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced its financial results and operational update for the period ending March 31, 2025. Highlights of the first quarter include: Commercial EndeavorsApproximately 50 hospitals are currently in the process of evaluating either VIVO, LockeT or both devices demonstrating that our new sales team continues to build a strong pipeline. After the close of the March quarter, the Company announced its acquisition of the assets of Cardionomics, Inc. through its newly formed, 82% owned subsidiary, Cardionomix, Inc. The acquired assets include Cardionomic’s Cardiac Pulmonary Nerve Stimulation System, a new therapy under development based upon novel...

Preparations for Phase 1/2 clinical trial in Australia utilizing fibroblast-based spheroids product candidate, CYWC628, to treat diabetic foot ulcers are proceeding with plans to initiate in the third quarter of 2025 HOUSTON, May 14, 2025 (GLOBE NEWSWIRE) — FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and pending for the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced first quarter 2025 financial results and provided a corporate update. Recent HighlightsAnnounced the completion of FibroBiologics’ proprietary master cell bank that will support upcoming clinical trials. Manufactured in accordance with FDA Good Manufacturing Practices (cGMP), the cell bank has successfully...

ZUG, Switzerland, May 14, 2025 (GLOBE NEWSWIRE) — Lithium Argentina AG (“Lithium Argentina” or the “Company”) (TSX: LAR) (NYSE: LAR) today announced its first quarter 2025 results. Unless otherwise stated, results are presented in United States dollar. Sam Pigott, Lithium Argentina’s President and CEO, commented: First-quarter performance highlights our focus on cost discipline at Cauchari-Olaroz. The operation performed as expected, with planned maintenance and optimization activities – aimed at enhancing long-term performance and reliability – temporarily reducing in production volumes. During April, the operation returned to above 85% capacity and is now seeing the benefits of these efforts. We remain on track to meet our 2025 guidance of 30,000-35,000 tonnes of lithium carbonate. Unit cash operating costs1 remained competitive...

PHOENIX, May 14, 2025 (GLOBE NEWSWIRE) — Global Water Resources, Inc. (NASDAQ: GWRS), a pure-play water resource management company, reported results for the first quarter ended March 31, 2025. All comparisons are to the same year-ago period unless otherwise noted. The company will hold a conference call at 1:00 p.m. Eastern time tomorrow to discuss the results (see dial-in information below). Q1 2025 Financial HighlightsTotal revenue increased 7.3% to $12.5 million, primarily due to organic connection growth and increased consumption. Net income decreased 14.5% to $0.6 million or $0.02 per share from $0.7 million or $0.03 per share. Adjusted EBITDA, a non-GAAP term, increased 4.4% to $5.6 million (see definition of adjusted EBITDA and its reconciliation to GAAP, below). Cash and cash equivalents totaled $31.5 million at March 31,...

Q1 2025 Revenue of $28.0 million Q1 2025 Net loss of $2.0 millionQ1 2025 Adjusted EBITDA loss of $2.5 millionAll figures are reported in United States dollars ($) unless otherwise indicatedLAS VEGAS, May 14, 2025 (GLOBE NEWSWIRE) — Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, today announced its financial results for the three-month period ended March 31, 2025. Planet 13’s financial statements are prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”). “This was a challenging quarter, marked by persistent pricing pressure and softness in tourism and consumer spending. Despite the headwinds, our differentiated brands and focus on entertainment continue to drive relative outperformance, reinforcing...

HOUSTON, May 14, 2025 (GLOBE NEWSWIRE) — Battalion Oil Corporation (NYSE American: BATL, “Battalion” or the “Company”) today announced financial and operating results for the first quarter of 2025. Key HighlightsGenerated first quarter 2025 sales volumes of 11,900 barrels of oil equivalent per day (“Boe/d”) (53% oil) Continued to lower capex per well, outperforming AFE estimates AGI facility online and treated 1.6 Bcf for the first quarter of 2025 Commenced drilling operations on final two wells of 2025 six-well planManagement Comments The Company has continued drilling operations as part of its previously announced 2025 six-well activity plan, completing four Monument Draw wells and drilling ahead of schedule on the remaining two wells in the West Quito area. Capital on first well post-TD in West Quito is approximately $1.0...

TORONTO, May 14, 2025 (GLOBE NEWSWIRE) — Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the three and six months ended March 31, 2025 and provided an update on its business. During the quarter, the company completed a $15 million equity financing from healthcare-focused institutional investors, existing Edesa shareholders and insiders to support the development of the company’s vitiligo drug candidate EB06, anti-CXCL10 monoclonal antibody. The company has subsequently initiated outreach to potential investigators and manufacturing-related activities to support U.S. regulatory approval for a Phase 2 study in moderate-to-severe nonsegmental vitiligo patients. “The initial steps in...

ATHENS, May 14, 2025 (GLOBE NEWSWIRE) — Okeanis Eco Tankers Corp. (together with its subsidiaries, unless context otherwise dictates, “OET” or the “Company”) (NYSE: ECO, OSE: OET) today reported its unaudited condensed financial results for the first quarter of 2025, which are attached to this press release. Financial performance of the First Quarter Ended March 31, 2025  • Revenues of $80.1 million in Q1 2025, compared to $111.1 million in Q1 2024.  • Profit of $12.6 million in Q1 2025, compared to $41.6 million in Q1 2024.  • Vessel operating expenses of $10.5 million in Q1 2025, compared to $10.6 in Q1 2024.  • Earnings per share of $0.39 in Q1 2025, compared to $1.29 in Q1 2024.  • Cash (including restricted cash) of $43.0 million as of March 31, 2025, compared to $54.3 million as of December 31, 2024.     Alternative...